Medicine News » General Medicine News » Eisai Announces Canadian Launch of Halaven™ (eribulin mesylate) Injection For ... - MarketWatch (press release)
Eisai Announces Canadian Launch of Halaven™ (eribulin mesylate) Injection For ... - MarketWatch (press release)
Posted on April 24th, 2012, 9:54 am
Canada NewsWire
Eisai Announces Canadian Launch of Halaven⢠(eribulin mesylate) Injection For ...